Clinical Study of Tanshinone Capsules Against COVID-19

Clinical trial NCT07123701 · COMPLETED

Trial details

NCT number: NCT07123701
Sponsor: Liu Shuwen
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 (Coronavirus Disease 2019)

Start date: 2024-03-01
Primary completion: 2025-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.